Abstract:Mood disorders remain a major public health concern worldwide. Monoaminergic hypotheses of pathophysiology of bipolar and major depressive disorders have led to the development of monoamine transporter-inhibiting antidepressants for the treatment of major depression and have contributed to the expanded indications of atypical antipsychotics for the treatment of bipolar disorders. In spite of psychopharmacological progress, current pharmacotherapy according to the monoaminergic hypothesis alone is insufficient to improve or prevent mood disorders. Recent approval of esketamine for treatment of treatment-resistant depression has attracted attention in psychopharmacology as a glutamatergic hypothesis of the pathophysiology of mood disorders. On the other hand, in the last decade, accumulated findings regarding the pathomechanisms of mood disorders emphasised that functional abnormalities of tripartite synaptic transmission play important roles in the pathophysiology of mood disorders. At first glance, the enhancement of astroglial connexin seems to contribute to antidepressant and mood-stabilising effects, but in reality, antidepressive and mood-stabilising actions are mediated by more complicated interactions associated with the astroglial gap junction and hemichannel. Indeed, several depressive mood-inducing stress stimulations suppress connexin43 expression and astroglial gap junction function, but enhance astroglial hemichannel activity. On the other hand, monoamine transporter-inhibiting antidepressants suppress astroglial hemichannel activity and enhance astroglial gap junction function, whereas several non-antidepressant mood stabilisers activate astroglial hemichannel activity. Based on preclinical findings, in this review, we summarise the effects of antidepressants, mood-stabilising antipsychotics, and anticonvulsants on astroglial connexin, and then, to establish a novel strategy for treatment of mood disorders, we reveal the current progress in psychopharmacology, changing the question from “what has been revealed?” to “what should be clarified?”.

Consequences on Behavior and Potential as Treatment Target

Astroglia in the Vulnerability to and Maintenance of Stress-Mediated Neuropathology and Depression

The role of astrocytes in depression, its prevention, and treatment by targeting astroglial gliotransmitter release

Astrocytes and Memory: Implications for the Treatment of Memory-related Disorders

Glucocorticoid Receptor–Dependent Astrocytes Mediate Stress Vulnerability

Gap junction channels as potential targets for the treatment of major depressive disorder

An astroglial basis of major depressive disorder: Molecular, Cellular, and Circuit Features

Astrocytes as Context for the Involvement of Myelin and Nodes of Ranvier in the Pathophysiology of Depression and Stress-Related Disorders

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Microglial glutaminase 1 mediates chronic restraint stress-induced depression-like behaviors and synaptic damages

Prefrontal Cortex Astroglia Modulate Anhedonia-like Behavior

Major depressive disorder and anxiety disorders from the glial perspective: Etiological mechanisms, intervention and monitoring

Astroglial Connexin43 as a Potential Target for a Mood Stabiliser

Impairments of Behavior, Information Flow Between Thalamus and Cortex, and Prefrontal Cortical Synaptic Plasticity in an Animal Model of Depression

The Association Between Antidepressant Effect of SSRIs and Astrocytes: Conceptual Overview and Meta‐analysis of the Literature

[Stress Mediated Microglial Hyper-Activation and Psychiatric Diseases]

Astrocytic glutamate regulation is implicated in the development of stress-related psychiatric disorders

Targeting Gap Junctions: New Insights into the Treatment of Major Depressive Disorder

Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

Microglial Responses to Stress-Induced Depression: Causes and Consequences